CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS - Patent 3802879

(19)

(11)

EP 3 802 879 A1

(12)

(43)	Date of publication:
	14.04.2021 Bulletin 2021/15

(21)	Application number: 19723768.8

(22)	Date of filing: 10.05.2019

(51)

International Patent Classification (IPC):

C12Q 1/6883^(2018.01)

(86)	International application number:
	PCT/EP2019/061998

(87)	International publication number:
	WO 2019/224014 (28.11.2019 Gazette 2019/48)

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME
	Designated Validation States:
	KH MA MD TN

(30)

Priority:

25.05.2018 DE 102018112644

(71)	Applicant: Precision for Medicine GmbH
	12489 Berlin (DE)

(72)	Inventors:
	OLEK, Sven 12207 Berlin (DE) HELD, Josephin 10318 Berlin (DE)

(74)	Representative: Krauss, Jan
	Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München 80336 München (DE)

(54)	CXCR3 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF INFLAMMATORY IMMUNE CELLS, IN PARTICULAR CD8+ MEMORY T CELLS